747
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice

, , , , , , , , & show all
Pages 1038-1047 | Received 10 Apr 2012, Accepted 08 May 2012, Published online: 01 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology 5:2.
Read now
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Philippe Erbs, Jean-Marc Limacher, Xavier Preville, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch:. OncoImmunology 3:6.
Read now
Gwenola Manic, Florine Obrist, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2014) Chloroquine and hydroxychloroquine for cancer therapy. Molecular & Cellular Oncology 1:1.
Read now
Erika Vacchelli, Nicole Prada, Oliver Kepp & Lorenzo Galluzzi. (2013) Current trends of anticancer immunochemotherapy. OncoImmunology 2:6.
Read now
Erika Vacchelli, Laura Senovilla, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:3.
Read now
Mariana Malvicini, Flavia Piccioni, Juan Bayo, Esteban Fiore, Catalina Atorrasagasti, Laura Alaniz, Mariana Garcia, Jorge B. Aquino, Manuel Gidekel, Pablo Matar & Guillermo Mazzolini. (2012) Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide. OncoImmunology 1:9, pages 1626-1628.
Read now

Articles from other publishers (14)

Sonia Aristin Revilla, Onno Kranenburg & Paul J. Coffer. (2022) Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting. Frontiers in Immunology 13.
Crossref
Pavlina Spiliopoulou, Samantha Hinsley, Iain A McNeish, Patricia Roxburgh & Ros Glasspool. (2021) Metronomic oral cyclophosphamide in relapsed ovarian cancer. International Journal of Gynecologic Cancer 31:7, pages 1037-1044.
Crossref
Hui Zhong, Yifan Lai, Rui Zhang, Abdelkader Daoud, Qingyuan Feng, Jia Zhou & Jing Shang. (2020) Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway. International Journal of Molecular Sciences 21:3, pages 957.
Crossref
Raja Pramanik & Sameer Bakhshi. (2019) Metronomic therapy in pediatric oncology: A snapshot. Pediatric Blood & Cancer 66:9.
Crossref
Jiemiao Hu, Chuang Sun, Chantale Bernatchez, Xueqing Xia, Patrick Hwu, Gianpietro Dotti & Shulin Li. (2018) T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors. Clinical Cancer Research 24:12, pages 2920-2934.
Crossref
Junjie Wu & David J. Waxman. (2018) Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy. Cancer Letters 419, pages 210-221.
Crossref
Marie Jordan & David J. Waxman. (2016) CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model. Cancer Letters 373:1, pages 88-96.
Crossref
Ruben Hernandez-Alcoceba, Joanna Poutou, María Cristina Ballesteros-Briones & Cristian Smerdou. (2016) Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12 . Immunotherapy 8:2, pages 179-198.
Crossref
Witold Lasek & Radoslaw ZagozdzonWitold Lasek & Marek Jakóbisiak. 2016. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology 21 41 .
E Peixoto, C Atorrasagasti, J B Aquino, R Militello, J Bayo, E Fiore, F Piccioni, E Salvatierra, L Alaniz, M G García, R Bataller, F Corrales, M Gidekel, O Podhajcer, M I Colombo & G Mazzolini. (2014) SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage. Gene Therapy 22:1, pages 9-19.
Crossref
Nicolas André, Manon Carré & Eddy Pasquier. (2014) Metronomics: towards personalized chemotherapy?. Nature Reviews Clinical Oncology 11:7, pages 413-431.
Crossref
José Manuel Bravo-San Pedro & Laura Senovilla. (2013) Immunostimulatory activity of lifespan-extending agents. Aging 5:11, pages 793-801.
Crossref
YONGBIN MOU, HAO XIE, XIAOFENG HUANG, WEI HAN, YANHONG NI, HANG SU, ZHIYONG WANG & QINGANG HU. (2013) Immunological suppression of head and neck carcinoma by dendritic cell tumor fusion vaccine. Oncology Letters 6:6, pages 1799-1803.
Crossref
Khursheed Anwer, F. Joseph Kelly, Christina Chu, Jason G. Fewell, Danny Lewis & Ronald D. Alvarez. (2013) Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer. Gynecologic Oncology 131:1, pages 169-173.
Crossref